We are live on ! Find out more
IART icon

Integra LifeSciences

158 hedge funds and large institutions have $2B invested in Integra LifeSciences in 2014 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 57 increasing their positions, 51 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

225% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 8

12% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 51

10% more funds holding

Funds holding: 143158 (+15)

3% less capital invested

Capital invested by funds: $2.06B → $2B (-$52.3M)

Holders
158
Holders Change
+15
Holders Change %
+10.49%
% of All Funds
4.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
26
Increased
57
Reduced
51
Closed
8
Calls
$347K
Puts
Net Calls
+$347K
Net Calls Change
+$10K

IART Hedge Fund Activity: Q4 2014 in Review

158 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q4 2014, worth a combined $2B — down 2.5% from $2.06B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new IART positions and 8 closed out — a net gain of 18 holders — while 57 added to existing stakes and 51 trimmed.

The largest buyer was Cramer Rosenthal McGlynn, opening a new position worth an estimated $8.38M. The largest seller was Invesco, cutting an estimated $35.7M.

  • 158 institutional investors held Integra LifeSciences (IART) as of Q4 2014, up from 143 in Q3 2014.
  • Funds reported $2B of Integra LifeSciences stock for Q4 2014, down 2.5% quarter-over-quarter.
  • 26 funds opened new Integra LifeSciences positions in Q4 2014 and 8 closed out, a net change of +18 holders.
  • The largest Integra LifeSciences buyer in Q4 2014 was Cramer Rosenthal McGlynn, an estimated $8.38M added.
  • The largest Integra LifeSciences seller in Q4 2014 was Invesco, an estimated $35.7M sold.

Based on aggregated 13F filings for Q4 2014.